Impact of Ethnicity on the Association of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms with Type 2 Diabetes Mellitus

被引：0
|
作者：
Al-Hamodi, Z. [1 ]
Saif-Ali, R. [1 ]
Ismail, I. S. [2 ]
Poh, R. [3 ]
Ahmed, R. H. [3 ]
Muniandy, S. [3 ]
机构：
[1] Fac Med, Dept Biochem & Mol Biol, Sanaa, Yemen
[2] Univ Malaya, Med Ctr, Dept Med, Kuala Lumpur 50603, Malaysia
[3] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia
来源：
PUBLIC HEALTH GENOMICS | 2015年 / 18卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
P056
引用
收藏
页码：30 / 30
页数：1
相关论文
共 50 条
  • [1] Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects
    Al-Hamodi, Zaid
    Saif-Ali, Riyadh
    Ismail, Ikram S.
    Ahmed, Khaled A.
    Muniandy, Sekaran
    [J]. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
  • [2] Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
    Zaid Al-Hamodi
    Ikram S Ismail
    Riyadh Saif-Ali
    Khaled A Ahmed
    Sekaran Muniandy
    [J]. Cardiovascular Diabetology, 10
  • [3] Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
    Al-Hamodi, Zaid
    Ismail, Ikram S.
    Saif-Ali, Riyadh
    Ahmed, Khaled A.
    Muniandy, Sekaran
    [J]. CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [4] Association of fibrinogen and plasminogen activator inhibitor-1 with diabetes mellitus
    Aziz, Iffat Ara
    Fawwad, Asher
    Siddiqui, Iftikhar Ahmed
    Perveen, Kahkashan
    Nangrejo, Ruqaya
    Waris, Nazish
    Basit, Abdul
    [J]. PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 35 (01) : 165 - 169
  • [5] Plasminogen Activator Inhibitor-1 and Tissue-Plasminogen Activator in Minority Adolescents with Type 2 Diabetes and Obesity
    Vatcharapan Umpaichitra
    M Mahmood Hussain
    Salvador Castells
    [J]. Pediatric Research, 2005, 58 : 483 - 487
  • [6] Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity
    Umpaichitra, V
    Hussain, MM
    Castells, S
    [J]. PEDIATRIC RESEARCH, 2005, 58 (03) : 483 - 487
  • [7] Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke
    Johansson, L
    Jansson, JH
    Boman, K
    Nilsson, TK
    Stegmayr, B
    Hallmans, G
    [J]. STROKE, 2000, 31 (01) : 26 - 32
  • [8] Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies
    Yasuda, S
    Tsutsumi, A
    Atsumi, T
    Bertolaccini, ML
    Ichikawa, K
    Khamashta, MA
    Hughes, GRV
    Koike, T
    [J]. JOURNAL OF RHEUMATOLOGY, 2002, 29 (06) : 1192 - 1197
  • [9] Genetic Architecture of Tissue-Type Plasminogen Activator and Plasminogen Activator Inhibitor-1
    Asselbergs, Folkert W.
    Pattin, Kristine
    Snieder, Harold
    Hillege, Hans L.
    van Gilst, Wiek H.
    Moore, Jason H.
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (06): : 562 - 568
  • [10] Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients
    Lindgren, A
    Lindoff, C
    Norrving, B
    Astedt, B
    Johansson, BB
    [J]. STROKE, 1996, 27 (06) : 1066 - 1071
12345